Oncological transformation in vitro of hepatic progenitor cell lines isolated from adult mice
dc.contributor.author | Olivera-Salazar, Rocío | |
dc.contributor.author | García-Arranz, Mariano | |
dc.contributor.author | Sánchez Muñoz, Aranzazu | |
dc.contributor.author | Olmedillas-López, Susana | |
dc.contributor.author | Vega-Clemente, Luz | |
dc.contributor.author | Serrano, Luis Javier | |
dc.contributor.author | Herrera González, Blanca María | |
dc.contributor.author | García-Olmo, Damián | |
dc.date.accessioned | 2024-07-24T11:48:29Z | |
dc.date.available | 2024-07-24T11:48:29Z | |
dc.date.issued | 2022-02-24 | |
dc.description.abstract | Colorectal cancer cells can transfer the oncogene KRAS to distant cells, predisposing them to malignant transformation (Genometastasis Theory). This process could contribute to liver metastasis;besides, hepatic progenitor cells (HPCs) have been found to be involved in liver malignant neoplasms. The objective of this study is to determine if mouse HPCs—Oval cells (OCs)—are susceptible to incorporate Kras GAT (G12D) mutation from mouse colorectal cancer cell line CT26.WT and if OCs with the incorporated mutation behave like malignant cells. To achieve this, three lines of OCs in diferent conditions were exposed to CT26.WT cells through transwell co-culture for a week. The presence of KrasG12D and capacity to form tumors were analyzed in treated samples by droplet digital PCR and colony-forming assays, respectively. The results showed that the KrasG12D mutation was detected in hepatic culture conditions of undiferentiated OCs and these cells were capable of forming tumors in vitro. Therefore, OCs are susceptible to malignant transformation by horizontal transfer of DNA with KrasG12D mutation in an undiferentiated condition associated with the liver microenvironment. This study contributes to a new step in the understanding of the colorectal metastatic process. | |
dc.description.department | Depto. de Bioquímica y Biología Molecular | |
dc.description.faculty | Fac. de Farmacia | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Instituto de Salud Carlos III (ISCIII) | |
dc.description.sponsorship | Fundación Conchita Rábago | |
dc.description.status | pub | |
dc.identifier.doi | 10.1038/s41598-022-06427-w | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.officialurl | https://doi.org/10.1038/s41598-022-06427-w | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/107121 | |
dc.journal.title | Scientific Reports | |
dc.language.iso | eng | |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//RD16%2F0011%2F0013/ES/Red de Terapia Celular (TerCel)/ | |
dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F01052/ES/VALOR DEL ESTUDIO DE LA PRESENCIA DIFERENCIAL DE EXONES EN LA BIOPSIA LIQUIDA DE PACIENTES CON CANCER DE RECTO QUE SIGUEN LA ESTRATEGIA “WATCH AND WAIT”/ | |
dc.rights | Attribution 4.0 International | en |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject.cdu | 577.1 | |
dc.subject.cdu | 577.2 | |
dc.subject.ucm | Biología molecular (Farmacia) | |
dc.subject.ucm | Bioquímica (Farmacia) | |
dc.subject.unesco | 32 Ciencias Médicas | |
dc.title | Oncological transformation in vitro of hepatic progenitor cell lines isolated from adult mice | |
dc.type | journal article | |
dc.type.hasVersion | AM | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 5ad3e4ea-8ef8-42a2-8f7b-ff372dc8d837 | |
relation.isAuthorOfPublication | 5827f207-2122-4faf-b1f3-7576ac372d56 | |
relation.isAuthorOfPublication.latestForDiscovery | 5ad3e4ea-8ef8-42a2-8f7b-ff372dc8d837 |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- Olivera-Salazar Scientific Reports 2022.pdf
- Size:
- 3.17 MB
- Format:
- Adobe Portable Document Format